Azmi Nabulsi, Chief Operating Officer at Phathom Pharmaceuticals, Inc. (PHAT), sold 15,772 shares at $6.59 ($104K) on 2025-01-21, disclosed to the SEC on 2025-01-23.
Seasonal sale ($104k) by Chief Operating Officer — this insider has traded PHAT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.59 | 7,886 | $52K | 50.0% |
| 2 | $6.59 | 7,886 | $52K | 50.0% |
| Total | $6.59 avg | 15,772 | $104K | 100% |
| Filing → |
| PHAT | BUY | 2023-04-11 | $83K | — | Filing → |
| PHAT | BUY | 2022-05-16 | $163K | — | Filing → |
| PHAT | SELL | 2021-05-04 | $1.1M | — | Filing → |